...Sirnaomics Inc. (Gaithersburg, Md.) hired Allan Shaw as CFO. He is a board member of Vivus Inc....

...global commercial products at Orexigen Therapeutics Inc. (La Jolla, Calif.). Cardiovascular, metabolic and pulmonary company Vivus Inc....

...Cardiovascular, metabolic and pulmonary company Vivus Inc. (NASDAQ:VVUS) said CEO Seth Fischer will step down. Thomas King...

...a serotonin 5-HT2C receptor agonist; Orexigen Therapeutics Inc. ’s Contrave naltrexone/bupropion, a MOR antagonist; and Vivus Inc....
...La Jolla, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of New South Wales, Sydney, Australia Vivus Inc....

...enlarge the GLP-1 market.” Lars Fruergaard Jørgensen, Novo Nordisk The next largest obesity product was Vivus Inc....
...the three obesity drugs launched over 2012-14, with placebo-adjusted reductions in body weight of 3.5-9.4%. Vivus...
...A/S (CSE:NOVOB; NYSE:NVO), Bagsvaerd, Denmark Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland University of Oxford, Oxford, U.K. Vivus Inc....

...EPS est 4Q15 EPS Expected chg SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) 3/6 Pre NA $0.30 NA Vivus Inc....

...Selten granted Vivus exclusive, worldwide rights to develop and commercialize tacrolimus and ascomycin to treat pulmonary...
...financial terms, and Selten referred questions to Vivus. Selten Pharma Inc. , San Carlos, Calif. Vivus Inc....
...Selten Pharma Inc. , San Carlos, Calif. Vivus Inc. (NASDAQ:VVUS), Campbell, Calif. Business: Cardiovascular Nora Weintraub Selten Pharma Inc. Vivus Inc....

...NASDAQ:JAZZ) 11/8 Post $2.61 $2.52 4% SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) 11/9 Post NA $0.23 NA Vivus Inc....

...to commercialize erectile dysfunction drug Stendra avanafil in the U.S., Canada, South America and India. Vivus...
...will be responsible for undisclosed royalties payable to Mitsubishi Tanabe Pharma Corp. (Tokyo:4508, Osaka, Japan). Vivus...
...Japan, China and certain other Pacific Rim countries. Stendra is a fast-acting phosphodiesterase-5 (PDE-5) inhibitor. Vivus Inc....

...Inc. (NYSE:EBS) 8/4 Post -$0.17 $0.36 NA PerkinElmer Inc. (NYSE:PKI) 8/4 Post $0.66 $0.60 10% Vivus Inc....